Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
Clearside Biomedical Cash from Investing (Quarterly): -0.12M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.12M |
| September 30, 2023 | -0.445M |
| June 30, 2023 | -1.097M |
| March 31, 2023 | -0.115M |
| December 31, 2022 | -0.091M |
| September 30, 2022 | -0.155M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.055M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2019 | 1.993M |
| March 31, 2019 | 30.93M |
| December 31, 2018 | 16.44M |
| September 30, 2018 | 0.375M |
| June 30, 2018 | -32.82M |
| March 31, 2018 | 12.24M |
| December 31, 2017 | 7.959M |
| September 30, 2017 | 13.07M |
| June 30, 2017 | 5.078M |
| March 31, 2017 | -5.99M |
| December 31, 2016 | -29.07M |
| September 30, 2016 | -20.07M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.024M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.004M |
| March 31, 2015 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.097M
Minimum
Jun 2023
1.993M
Maximum
Jun 2019
-0.0045M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Cassava Sciences Inc | -0.041M |
| Heron Therapeutics Inc | -8.836M |
| Actinium Pharmaceuticals Inc | -0.011M |
| Karyopharm Therapeutics Inc | 26.84M |
| Ocular Therapeutix Inc | -0.459M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.495M |
| Cash from Financing (Quarterly) | -0.257M |
| Free Cash Flow | -19.91M |
| Free Cash Flow Per Share (Quarterly) | 0.006 |
| Free Cash Flow to Equity (Quarterly) | 0.375M |
| Free Cash Flow Yield | -24.59% |